The medical term is (deep breath) keratoconjunctivitis sicca. It’s a daunting name for a common condition that affects one-fifth of all adults. An estimated 3 million new cases occur each year.

Erin Andrews will be working another Super Bowl for Fox Sports this season. The Kansas City Chiefs are taking on the ...

Iolyx Therapeutics engaged in research and development focused on autoimmunity and ophthalmology to offer novel treatments for ocular diseases. The company is headquartered in Menlo Park, California, ...

Selenium sulfide is under clinical development by Azura Ophthalmics and currently in Phase III for Keratoconjunctivitis Sicca (Dry Eye). According to GlobalData, Phase III drugs for ...

Keratoconjunctivitis sicca is the most common manifestation. However, vision loss may result from involvement of the retina, choroid and optic nerve. Ocular symptoms are correlated to systemic disease ...

BACKGROUND/AIMS Autologous serum drops have been reported to be beneficial in keratoconjunctivitis sicca (KCS) and persistent epithelial defects (PED). A clinical pilot study was carried out to ...

The American Academy of Opthalmology recommends allowing more time for your eye to heal if you have epidemic keratoconjunctivitis (EKC). EKC is highly transmissible, usually affects both eyes ...

Figure 2 provides a birds-eye view of the current and future trends in the management of severe OSD. Current management may not completely restore the functions and structure of the ocular surface ...